Jaswant Singh Khera
Director/Board Member at WEP Group Holdings Ltd.
Jaswant Singh Khera active positions
Companies | Position | Start | End |
---|---|---|---|
WEP Group Holdings Ltd.
WEP Group Holdings Ltd. Medical DistributorsDistribution Services WEP Group Holdings Ltd. was founded in 2017 and is a British company that creates broader treatment access solutions for patients worldwide. The company is based in London, UK, and has subsidiaries in the United Kingdom. The company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them. | Director/Board Member | 18/12/2017 | - |
WE Pharma Ltd.
WE Pharma Ltd. Medical DistributorsDistribution Services Part of WEP Group Holdings Ltd., WE Pharma Ltd. creates broader treatment access solutions for patients worldwide. The company is based in London, UK. The British company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them. | Director/Board Member | - | - |
Career history of Jaswant Singh Khera
Statistics
International
United Kingdom | 3 |
Operational
Director/Board Member | 2 |
Sectoral
Distribution Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
WEP Group Holdings Ltd.
WEP Group Holdings Ltd. Medical DistributorsDistribution Services WEP Group Holdings Ltd. was founded in 2017 and is a British company that creates broader treatment access solutions for patients worldwide. The company is based in London, UK, and has subsidiaries in the United Kingdom. The company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them. | Distribution Services |
WE Pharma Ltd.
WE Pharma Ltd. Medical DistributorsDistribution Services Part of WEP Group Holdings Ltd., WE Pharma Ltd. creates broader treatment access solutions for patients worldwide. The company is based in London, UK. The British company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them. | Distribution Services |
- Stock Market
- Insiders
- Jaswant Singh Khera
- Experience